封面
市場調查報告書
商品編碼
1455767

全球食品補充品市場 - 2023-2030

Global Food Supplement Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 250 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年,全球食品補充劑市場規模達到1,728.9億美元,預計2030年將達到3,451.3億美元,2023-2030年預測期間CAGR為8.4%。

食品補充劑市場擴張的根本驅動力是人口老化是不可阻擋的全球趨勢。隨著年齡的成長,他們經常會遇到各種健康問題和疾病,包括免疫系統衰弱、關節問題和骨骼健康問題。老年人越來越被針對這些特定健康問題的食品補充劑所吸引。

新陳代謝的變化、食慾下降和難以維持健康飲食是老化的常見副作用。對於老年人來說,食品補充劑提供了一種實用的方法來滿足他們的營養需求並保證他們獲得重要的維生素、礦物質和其他營養素。老年人可能患有慢性健康問題,例如糖尿病、心血管問題或與年齡相關的黃斑部病變。

維生素成分細分市場佔三分之一的市場佔有率,亞太地區在食品補充劑市場佔據主導地位。由於意識、人口和可支配收入的增加,亞太地區膳食補充劑市場正在經歷快速成長。由於人口老化等多種因素,印度、中國和日本等國家的需求也增加。

動力學

人口老化加劇

人口老化是不可逆轉的全球趨勢,也是市場發展的重要催化劑。隨著年齡的成長,個人經常面臨各種健康問題和狀況,例如關節問題、骨骼健康問題、認知能力下降和免疫系統減弱。旨在解決這些特定健康問題的食品補充劑對老齡化人口更具吸引力。老化通常伴隨著新陳代謝的變化、食慾下降以及維持均衡飲食的挑戰。

認知能力下降是老年人普遍關心的問題。含有 omega-3 脂肪酸、抗氧化劑和其他被認為有助於大腦健康的營養素的補充劑通常面向老年人群,以促進認知功能和記憶力。因此,老齡化人口的增加有助於推動市場成長。例如,根據世界衛生組織2022年估計,60歲及以上人口比例將從2020年的10億增加到14億,到2050年,全球60歲及以上人口將翻倍(21億) )。 2020 年至 2050 年間,80 歲及以上的人口數量預計將增加兩倍,達到 4,260 億。

增加營養的個性化

個人化營養可以更準確地識別個人營養缺乏或特定的健康目標。因此,食品補充劑製造商可以開發出滿足這些特定需求的有針對性的產品,為消費者提供更量身定做和有效的解決方案。基因檢測和個人化健康評估等技術進步使得客製化補充劑配方的創建成為可能。個人可以獲得與其獨特的基因組成、生活方式和健康狀況相符的補充劑。這種程度的客製化增加了補充劑的感知價值,推動了消費者的興趣和市場的成長。

個人化營養使消費者能夠更好地控制自己的健康和福祉。隨著人們越來越意識到自己的營養需求,他們可能會尋求滿足其特定需求的個人化補充劑。這種對個人化解決方案的需求有助於食品補充劑市場的擴大。例如,國際食品資訊理事會2023年估計,北美消費者越來越被個人化營養產品所吸引。事實上,46% 的美國人希望獲得更個人化的建議和解決方案來支持他們的健康。同樣,55% 的加拿大成年人表示,他們會對基於 DNA 分析的營養計劃感興趣。目前,出現了兩種主要的消費者群體,一種是有特定健康問題的老年人,另一種是數位化程度最高的一代(千禧世代和Z世代)。因此,上述因素有助於推動市場成長。

與食品補充劑相關的副作用

與食品補充劑相關的副作用會嚴重抑制市場的成長。消費者越來越擔心他們所消費的產品的安全性和潛在的不利影響。副作用的存在可能導致消費者信心下降、監管審查和負面宣傳。嚴重的副作用可能會導致產品召回,這不僅成本高昂,還會損害品牌聲譽。由於與補充劑消費相關的健康問題而對製造商採取的法律行動也可能導致經濟損失。例如,2023 年 10 月,Botanical-Be 回收了某些受雙氯芬酸污染的膳食補充劑,根據 FDA 的說法,膳食補充劑中存在雙氯芬酸等活性藥物成分,導致這些產品未經批准。

服用過多的補充劑可能會導致患者增加人體內的毒性。服用過多的鈣補充劑可能會導致結石或高鈣血症。許多補充劑也會引起腹瀉。有時,身體可能無法吸收這些補充劑,它們也可能會隨著尿液被沖走。使用處方藥的消費者可能會對與補充劑的潛在交互作用持謹慎態度。補充劑如何與現有藥物相互作用的不確定性可能會阻礙一些人使用它們。因此,上述因素抑制了市場的成長。

目錄

目錄

第 1 章:方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章:定義與概述

第 3 章:執行摘要

  • 按成分分類
  • 按表格列出的片段
  • 按應用程式片段
  • 最終使用者的片段
  • 按配銷通路分類的片段
  • 按地區分類的片段

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 人口老化加劇
      • 增加營養的個性化
    • 限制
      • 天然替代品與全食趨勢
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章:按成分

  • 維生素
  • 植物藥
  • 礦物質
  • 蛋白質和胺基酸
  • 歐米伽脂肪酸
  • 其他

第 8 章:按形式

  • 藥片
  • 膠囊
  • 軟膠囊
  • 粉末
  • 軟糖
  • 液體
  • 其他

第 9 章:按應用

  • 能量和體重管理
  • 整體健康
  • 骨骼和關節健康
  • 腸胃健康
  • 免疫
  • 心臟健康
  • 糖尿病
  • 其他

第 10 章:最終用戶

  • 成年人
  • 老年科
  • 孕婦
  • 孩子們
  • 嬰兒

第 11 章:按配銷通路

  • 離線
  • 線上

第 12 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第13章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 14 章:公司簡介

  • Amway
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Abbott Laboratories
  • Bayer AG
  • Pfizer Inc
  • ADM
  • Carlyle Nutritionals LLC
  • Glanbia Plc
  • Haleon Plc
  • Otsuka Holdings Co Ltd
  • Herballife Ltd

第 15 章:附錄

簡介目錄
Product Code: FB8228

Overview

Global Food Supplement Market reached US$ 172.89 billion in 2022 and is expected to reach US$ 345.13 billion by 2030, growing with a CAGR of 8.4% during the forecast period 2023-2030.

The essential driver of market expansion of food supplements is the aging population is an unstoppable global trend. As people get older, they frequently experience a variety of health difficulties and ailments, including immune system weakness, joint problems, and problems with bone health. The older population is increasingly drawn to food supplements made to target these particular health problems.

Changes in metabolism, decreased appetite, and difficulties keeping up a healthy diet are common side effects of aging. For older people, food supplements offer a practical means of fulfilling their nutritional needs and guaranteeing they get vital vitamins, minerals, and other nutrients. Older individuals may have chronic health conditions such as diabetes, cardiovascular issues, or age-related macular degeneration.

The vitamin ingredient segment accounts for one-third market share and Asia Pacific dominates the food supplement market. The Asia-Pacific dietary supplements market is experiencing rapid growth due to increasing awareness, population, and disposable incomes. Demand in countries like India, China, and Japan has also increased due to the aging population and other various factors.

Dynamics

Rise in the aging population

The aging population is an irreversible global trend that is a crucial catalyst for market development. With age, individuals often face various health concerns and conditions, such as joint issues, bone health problems, cognitive decline, and weakened immune systems. Food supplements designed to address these specific health issues become more appealing to the aging population. Aging is often accompanied by changes in metabolism, reduced appetite, and challenges in maintaining a balanced diet.

Cognitive decline is a common concern among the elderly. Supplements containing omega-3 fatty acids, antioxidants, and other nutrients believed to support brain health are often marketed to the aging population to promote cognitive function and memory. Thus, the rise of the aging population helps to boost the market growth. For instance, according to WHO 2022, estimated that the share of the population aged 60 years and over, will increase from 1 billion in 2020 to 1.4 billion, by 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 billion.

Increasing the personalization of nutrition

Personalized nutrition allows for more precise identification of individual nutrient deficiencies or specific health goals. As a result, food supplement manufacturers can create targeted products that address these specific needs, offering consumers a more tailored and effective solution. Advances in technology, such as genetic testing and personalized health assessments, enable the creation of customized supplement formulations. Individuals can receive supplements that align with their unique genetic makeup, lifestyle, and health conditions. This level of customization increases the perceived value of supplements, driving consumer interest and market growth.

Personalized nutrition empowers consumers by giving them greater control over their health and well-being. As people become more conscious of their nutritional requirements, they are likely to seek out personalized supplements that cater to their specific needs. This demand for personalized solutions contributes to the expansion of the food supplements market. For instance, to International Food Information Council, 2023, estimated that North American consumers are increasingly attracted to personalized nutrition products. Indeed, 46% of Americans would like more personalized advice and solutions to support their health. Similarly, 55% of Canadian adults say they would be interested in a nutritional plan based on DNA analysis. Currently, two main consumer profiles are emerging, one is senior citizens with specific health problems, and the other is the most digital generation (Millennials and Generation Z). Thus, the above factors help to boost the market growth.

Side effects associated with food supplements

Side effects associated with food supplements can significantly restrain the growth of the market. Consumers are increasingly concerned about the safety and potential adverse effects of the products they consume. The presence of side effects can lead to a decline in consumer confidence, regulatory scrutiny, and negative publicity. Serious side effects may lead to product recalls, which can be costly and damaging to a brand's reputation. Legal action against manufacturers due to health issues linked to supplement consumption can also result in financial losses. For instance, in October 2023, Botanical-Be recalls certain dietary supplements tainted with diclofenac, according to the FDA, the presence of an active pharmaceutical ingredient such as diclofenac in a dietary supplement renders these products unapproved drugs.

Taking too many supplements may cause patients to increase the toxicity in the human body. Taking too many calcium supplements may lead to stones or hypercalcemia. Many supplements also cause diarrhea. Sometimes the body might not absorb these supplements and they could be washed away in the urine as well. Consumers, using prescription medications may be cautious about potential interactions with supplements. The uncertainty about how supplements may interact with existing medications can discourage some individuals from using them. Thus, above factors restrain market growth.

Segment Analysis

The global food supplement market is segmented based on ingredient, form, application, end-user distribution channel and region.

Rise in Vitamin Deficiency

Certain vitamins, such as vitamin C and vitamin D, play a crucial role in supporting the immune system. During times of increased susceptibility to illness or when the body is under stress, vitamin supplements can provide an extra layer of immune support. Vitamins like D and K are essential for bone health and calcium absorption. In cases where dietary sources are insufficient, supplements can help maintain strong and healthy bones, reducing the risk of conditions like osteoporosis. B-complex vitamins, including B1, B2, B3, B6, and B12, are integral for energy metabolism. Supplements can contribute to sustained energy levels, making them particularly relevant for individuals with increased energy demands or those experiencing fatigue.

Insufficient intake of vitamin A can affect vision and immune function, while a lack of vitamin K may impair blood clotting. It is essential to maintain a well-balanced diet to prevent such deficiencies, but in some cases, supplementation may be necessary, especially for individuals with specific dietary restrictions or medical conditions affecting nutrient absorption. Regular health check-ups and consultations with healthcare professionals can help identify and address potential vitamin deficiencies. Thus, the rise of vitamin deficiency helps to boost the segment growth. For instance, according to World in Data 2021. Globally, it's estimated that over half of children under five years old are micronutrient deficient (in at least one of iron, zinc, and vitamin A). In addition, over two-thirds of non-pregnant women of reproductive age are micronutrient deficient (in at least one of iron, zinc, and folate also known as vitamin B9)

Geographical Penetration

Growing Awareness about Food Supplements in Asia-Pacific

The Asia-Pacific dietary supplements market is experiencing rapid growth due to increasing awareness, population, and disposable incomes. Demand in countries like India, China, and Japan has also increased due to the ageing population and other various factors. In China, the food supplements terminology is mentioned as Health Food which refers to foods that claim to have specific health functions or provide vitamins and minerals. It is specific to certain groups and modifies organic functions in humans, but is not intended to treat disease and does not cause acute, sub-acute, or chronic harm to the human body.

In 2021, the scope of health food filing was expanded. In addition, according to the drafts issued by SAMR on 20 December 2021, 6 ingredients including DHA, soybean protein isolate, whey protein, etc., will be added to the health food raw material directory, which means, more ingredients will be available for health food filing in the future. On the other hand, after the abolishment of Technical Standards for Testing & Assessment of healthy food, the registration tests of new products in China have been suspended. At present, most test methods have been officially issued, and it can be expected the functional assessment methods will be released in 2022. Meanwhile, China authorities paid great attention to the R&D materials during the technical review of product registration dossiers, and sufficient scientific literature support is a focus of the review. Therefore, when preparing the registration dossier, enterprises shall attach importance to the collection of them.

COVID-19 Impact Analysis

The COVID-19 pandemic led to widespread disruptions in global supply chains, affecting the production and distribution of various goods, including dietary supplements. Restrictions on movement, lockdown measures, and workforce shortages disrupted the supply of raw materials and manufacturing processes for Food Supplement. This resulted in delays in production, shortages in supply, and increased costs for manufacturers, impacting the availability of Food Supplement in the market.

However, the pandemic prompted a shift in consumer priorities towards health and wellness. With heightened awareness of immune health and overall well-being, there was increased interest in dietary supplements, including those containing isoflavones. Consumers sought products that could potentially support their immune systems and help manage stress and anxiety during uncertain times. This shift in consumer behavior led to a surge in demand for Food supplements, particularly those marketed for their potential health benefits.

By Ingredient

  • Vitamins
  • Vitamins
  • Botanicals
  • Minerals
  • Proteins and Amino Acids
  • Omega Fatty Acids
  • Others

By Form

  • Tablet
  • Capsules
  • Soft Gels
  • Powders
  • Gummies
  • Liquids
  • Others

By Application

  • Energy and Weight Management
  • General Health
  • Bone and Joint Health
  • Gastrointestinal Health
  • Immunity
  • Cardiac Health
  • Diabetes
  • Others

By End-User

  • Adults
  • Geriatric
  • Pregnant Women
  • Children
  • Infants

By Distribution Channel

  • Offline
  • Online

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, a new brand from Abbott Laboratories (PROTALITY) was launched into the market in 2024 to improve the product portfolio of Abbott nutrition, a part of Abbott Laboratories. The high-protein nutrition shake is the first product in this line to support the growing number of adults interested in pursuing weight loss while maintaining muscle mass and good nutrition.
  • In February 2024, Performance Lab launched nine new single-supplement nutrients. The nine supplements include Vitamin B-Complex, Calcium, Iron Complex, Magnesium, Potassium and Vitamin C, as well as the lesser known, but most important, Iodine, Selenium and Zinc.
  • In September 2023, Probiotix Health Plc launched a new formulation designed for high end heart health supplements and online brands in the nutraceuticals market looking to expand cardiovascular health offerings.

Competitive Landscape

The major global players in the market include Amway, Abbott Laboratories, Bayer AG, Pfizer Inc, ADM, Carlyle Nutritionals LLC, Haleon Plc, Glanbia Plc, Otsuka Holdings Co Ltd, Herbalife Ltd are strategically partnering with healthcare professionals, nutritionists, and dietitians

Why Purchase the Report?

  • To visualize the global Food Supplement market segmentation based on Ingredient, form, application, end user, distribution channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of food supplements at the market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global Food Supplement market report would provide approximately 78 tables, 85 figures, and 250 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Ingredient
  • 3.2.Snippet by Form
  • 3.3.Snippet by Application
  • 3.4.Snippet by End User
  • 3.5.Snippet by Distribution Channel
  • 3.6.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Rise in aging population
      • 4.1.1.2.Increasing the personalization of nutrition
    • 4.1.2.Restraints
      • 4.1.2.1.The natural Alternatives and Whole foods trend
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.Russia-Ukraine War Impact Analysis
  • 5.6.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Ingredient

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredients
    • 7.1.2.Market Attractiveness Index, By Ingredients
  • 7.2.Vitamins*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Botanicals
  • 7.4.Minerals
  • 7.5.Proteins and Amino Acids
  • 7.6.Omega Fatty Acids
  • 7.7.Others

8.By Form

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2.Market Attractiveness Index, By Form
  • 8.2.Tablet*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Capsules
  • 8.4.Soft Gels
  • 8.5.Powders
  • 8.6.Gummies
  • 8.7.Liquids
  • 8.8.Others

9.By Application

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2.Market Attractiveness Index, By Application
  • 9.2.Energy and Weight Management*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.General Health
  • 9.4.Bone and Joint Health
  • 9.5.Gastrointestinal Health
  • 9.6.Immunity
  • 9.7.Cardiac Health
  • 9.8.Diabetes
  • 9.9.Others

10.By End User

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2.Market Attractiveness Index, By End User
  • 10.2.Adults*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Geriatric
  • 10.4.Pregnant Women
  • 10.5.Children
  • 10.6.Infants

11.By Distribution Channel

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2.Market Attractiveness Index, By Distribution Channel
  • 11.2.Offline*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Online

12.By Region

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2.Market Attractiveness Index, By Region
  • 12.2.North America
    • 12.2.1.Introduction
    • 12.2.2.Key Region-Specific Dynamics
    • 12.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1.U.S.
      • 12.2.8.2.Canada
      • 12.2.8.3.Mexico
  • 12.3.Europe
    • 12.3.1.Introduction
    • 12.3.2.Key Region-Specific Dynamics
    • 12.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1.Germany
      • 12.3.8.2.UK
      • 12.3.8.3.France
      • 12.3.8.4.Italy
      • 12.3.8.5.Russia
      • 12.3.8.6.Rest of Europe
  • 12.4.South America
    • 12.4.1.Introduction
    • 12.4.2.Key Region-Specific Dynamics
    • 12.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1.Brazil
      • 12.4.8.2.Argentina
      • 12.4.8.3.Rest of South America
  • 12.5.Asia-Pacific
    • 12.5.1.Introduction
    • 12.5.2.Key Region-Specific Dynamics
    • 12.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1.China
      • 12.5.8.2.India
      • 12.5.8.3.Japan
      • 12.5.8.4.Australia
      • 12.5.8.5.Rest of Asia-Pacific
  • 12.6.Middle East and Africa
    • 12.6.1.Introduction
    • 12.6.2.Key Region-Specific Dynamics
    • 12.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
    • 12.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 12.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13.Competitive Landscape

  • 13.1.Competitive Scenario
  • 13.2.Market Positioning/Share Analysis
  • 13.3.Mergers and Acquisitions Analysis

14.Company Profiles

  • 14.1. Amway*
    • 14.1.1.Company Overview
    • 14.1.2.Product Portfolio and Description
    • 14.1.3.Financial Overview
    • 14.1.4.Key Developments
  • 14.2.Abbott Laboratories
  • 14.3.Bayer AG
  • 14.4.Pfizer Inc
  • 14.5.ADM
  • 14.6.Carlyle Nutritionals LLC
  • 14.7.Glanbia Plc
  • 14.8.Haleon Plc
  • 14.9.Otsuka Holdings Co Ltd
  • 14.10.Herballife Ltd

LIST NOT EXHAUSTIVE

15.Appendix

  • 15.1.About Us and Services
  • 15.2.Contact Us